Steven N. Goodman

Add links
From Wikipedia, the free encyclopedia
Steven N Goodman
CitizenshipAmerican
EducationAB, Harvard College, Biochemistry, Applied Math (1976)
Alma materHarvard University
New York University
Johns Hopkins School of Public Health;
Known for"Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy, and 2: The Bayes Factor"
AwardsSpinoza Chair in Medicine (2016), National Academy of Medicine (2020)
Scientific career
FieldsMedical Research, Epidemiology, Statistics, Metascience
Thesis Evidence and Clinical Trials  (1989)
Doctoral advisorRichard Royall
Other academic advisorsCurt Meinert

Steven N. Goodman (born 1954) is an American Professor of Epidemiology and Population Health and of Medicine at the Stanford School of Medicine.[1] He has extensively contributed to foundations of scientific and statistical inference within the biosciences, and in 1999 he coined the term "p-value fallacy".[2]

Works[edit]

He has made numerous contributions to the methods of clinical research, comparative effectiveness, meta analysis, and scientific inference,[3][4][5][6][7][8][9][10][11][12][13][14] in addition to works on scientific evidence.[15][16][17][18][19][20][21][22][23][24][25][26][27][28]

References[edit]

  1. ^ "Steven Goodman".
  2. ^ Sellke, Thomas; Bayarri, M. J; Berger, James O (February 2001). "Calibration of ρ Values for Testing Precise Null Hypotheses". The American Statistician. 55 (1): 62–71. doi:10.1198/000313001300339950. S2CID 396772.
  3. ^ Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., Goodman, S. N. (2014). "Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change". Annals of Internal Medicine. 160 (4): 267–270. doi:10.7326/M13-2886. PMID 24727843. S2CID 9210956.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ^ Basch, E., Aronson, N., Berg, A., Flum, D., Gabriel, S., Goodman, S. N., Helfand, M., Ioannidis, J. P., Lauer, M., Meltzer, D., Mittman, B., Newhouse, R., Normand, S., Schneeweiss, S., Slutsky, J., Tinetti, M., Yancy, C. (2012). "Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research The PCORI Perspective". JAMA. 307 (15): 1636–1640. doi:10.1001/jama.2012.466. PMID 22511692.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ^ Goodman, S. N. (2012). "Quasi-random reflections on randomized controlled trials and comparative effectiveness research". Clinical Trials. 9 (1): 22–26. doi:10.1177/1740774511433285. PMID 22334465. S2CID 22693531.
  6. ^ Sox, H. C., Goodman, S. N. (2012). "The Methods of Comparative Effectiveness Research". Annual Review of Public Health. 33: 425–445. doi:10.1146/annurev-publhealth-031811-124610. PMID 22224891.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ^ Goodman, S., Dickersin, K. (2011). "Metabias: A Challenge for Comparative Effectiveness Research". Annals of Internal Medicine. 155 (1): 61–2. doi:10.7326/0003-4819-155-1-201107050-00010. PMID 21727295. S2CID 43451703.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  8. ^ Luce, B. R., Kramer, J. M., Goodman, S. N., Connor, J. T., Tunis, S., Whicher, D., Schwartz, J. S. (2009). "Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change". Annals of Internal Medicine. 151 (3): 206–209. doi:10.7326/0003-4819-151-3-200908040-00126. PMID 19567619.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. ^ Goodman SN, Greenland S (2007). "Assessing the unreliability of the medical literature: A response to "Why most published research findings are false"". Archived from the original on 2012-04-06. {{cite journal}}: Cite journal requires |journal= (help)
  10. ^ Goodman, S. N. (2002). "The mammography dilemma: A crisis for evidence-based medicine?". Annals of Internal Medicine. 137 (5): 363–365. doi:10.7326/0003-4819-137-5_part_1-200209030-00015. PMID 12204023. S2CID 40784168.
  11. ^ Goodman, S. N., Zahurak, M. L., PIANTADOSI, S. (1995). "Some practical improvements in the continual reassessment method for phase I studies". Statistics in Medicine. 14 (11): 1149–1161. doi:10.1002/sim.4780141102. PMID 7667557.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. ^ Goodman, S. N., Berlin, J. A. (1994). "The Use of Predicted Confidence Intervals when Planning Experiments and the Misuse of Power when Interpreting Results". Annals of Internal Medicine. 121 (3): 200–206. doi:10.7326/0003-4819-121-3-199408010-00008. PMID 8017747. S2CID 53089940.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  13. ^ Goodman, S. N. (1989). "Meta-analysis and evidence". Controlled Clinical Trials. 10 (2): 188–204. doi:10.1016/0197-2456(89)90030-5. PMID 2666026.
  14. ^ Goodman, S. N., Royall, R. (1988). "Evidence and scientific research". American Journal of Public Health. 78 (12): 1568–1574. doi:10.2105/ajph.78.12.1568. PMC 1349737. PMID 3189634.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ^ Glass, T. A., Goodman, S. N., Hernán, M. A., Samet, J. M. (2013). "Causal inference in public health". Annual Review of Public Health. 34: 61–75. doi:10.1146/annurev-publhealth-031811-124606. PMC 4079266. PMID 23297653.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. ^ Faden, R. R., Kass, N. E., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics". Hastings Center Report. 43: S16-27. doi:10.1002/hast.134. PMID 23315888.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  17. ^ Kass, N. E., Faden, R. R., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "The Research-Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight". Hastings Center Report. 43: S4–S15. doi:10.1002/hast.133. PMID 23315895.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. ^ Mello, M. M., Goodman, S. N., Faden, R. R. (2012). "Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report". New England Journal of Medicine. 367 (10): 959–964. doi:10.1056/NEJMhle1207160. PMID 22913661. S2CID 36551817.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. ^ Goodman, S. (2011). "Confessions of a chagrined trialist". BMJ Quality & Safety. 20 (Suppl_1): i97–i98. doi:10.1136/bmjqs.2010.046623. PMC 3066790. PMID 21450783.
  20. ^ Goodman, S. N. (2007). "Stopping at nothing? Some dilemmas of data monitoring in clinical trials". Annals of Internal Medicine. 146 (12): 882–887. doi:10.7326/0003-4819-146-12-200706190-00010. PMID 17577008. S2CID 21243453.
  21. ^ Laine, C., Goodman, S. N., Griswold, M. E., Sox, H. C. (2007). "Reproducible research: Moving toward research the public can really trust". Annals of Internal Medicine. 146 (6): 450–453. doi:10.7326/0003-4819-146-6-200703200-00154. PMID 17339612. S2CID 1359523.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  22. ^ Goodman, S. N., Sladky, J. T. (2005). "A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain–Barre syndrome". Clinical Trials. 2 (4): 305–310. doi:10.1191/1740774505cn102oa. PMID 16281429. S2CID 22919090.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  23. ^ Goodman, S. N. (2001). "Of P-values and bayes: A modest proposal". Epidemiology. 12 (3): 295–297. doi:10.1097/00001648-200105000-00006. PMID 11337600. S2CID 41986475.
  24. ^ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 1: The P value fallacy". Annals of Internal Medicine. 130 (12): 995–1004. doi:10.7326/0003-4819-130-12-199906150-00008. PMID 10383371. S2CID 7534212.
  25. ^ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 2: The Bayes factor". Annals of Internal Medicine. 130 (12): 1005–1013. doi:10.7326/0003-4819-130-12-199906150-00019. PMID 10383350. S2CID 13186212.
  26. ^ Goodman, S. N., Berlin, J., Fletcher, S. W., Fletcher, R. H. (1994). "Manuscript Quality before and after Peer Review and Editing at Annals of Internal Medicine". Annals of Internal Medicine. 121 (1): 11–21. doi:10.7326/0003-4819-121-1-199407010-00003. PMID 8198342. S2CID 5716602.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  27. ^ Goodman, S. N. (1993). "P Values, Hypothesis Tests, and Likelihood: Implications for Epidemiology of a Neglected Historical Debate". American Journal of Epidemiology. 137 (5): 485–496. doi:10.1093/oxfordjournals.aje.a116700. PMID 8465801.
  28. ^ Goodman, S. N. (1992). "A comment on replication, P-values and evidence". Statistics in Medicine. 11 (7): 875–879. doi:10.1002/sim.4780110705. PMID 1604067.

External links[edit]

  • Esteller, Manel; Garcia-Foncillas, Jesus; Andion, Esther; Goodman, Steven N.; Hidalgo, Oscar F.; Vanaclocha, Vicente; Baylin, Stephen B.; Herman, James G. (2000). "Cancer research: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents". New England Journal of Medicine. 343 (19): 1350–1354. doi:10.1056/NEJM200011093431901. hdl:2445/176306. PMID 11070098. S2CID 40303322.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Steven_N._Goodman&oldid=1192937341"